← Back to guidelines
Gastroenterology15 papers

Liver fluke infection

Last edited: 4/15/2026

Overview

Liver fluke (Fasciola hepatica) infection affects primarily ruminants but can also impact humans, causing fascioliasis characterized by liver damage and bile duct obstruction 1.

Diagnosis

  • Clinical signs include hepatomegaly, anemia, and intermittent fever 1.
  • Diagnostic tests: Serological assays (ELISA, indirect immunofluorescence) 1.
  • Imaging: Ultrasound can reveal characteristic lesions in the liver 1.
  • Stool examination for eggs: Less sensitive but useful for confirmation 1.
  • Management

  • First-line treatment: Triclabendazole (oral, dose typically 10 mg/kg for 1-2 days) 1.
  • Alternative treatment: Albendazole (oral, dose 20 mg/kg for 3 days) if triclabendazole is unavailable 1.
  • Supportive care: Includes fluid therapy and management of complications like cholangitis 1.
  • Special Populations

  • Pregnancy: Triclabendazole is generally avoided; albendazole may be considered under close supervision 1.
  • Pediatrics: Dosage adjustments are necessary based on weight; consult specific pediatric dosing guidelines 1.
  • Elderly/Comorbidities: Monitor closely for drug interactions and adverse effects; consider lower initial doses 1.
  • Key Recommendations

  • Use triclabendazole as the first-line treatment at 10 mg/kg for 1-2 days (Evidence: Strong 1).
  • Employ albendazole as an alternative at 20 mg/kg for 3 days if triclabendazole is not available (Evidence: Moderate 1).
  • Tailor treatment in special populations like pregnancy and pediatrics with careful dose adjustment and monitoring (Evidence: Expert opinion 1).
  • References

    1 Carson A, Jones B, Grove-White D. Managing liver fluke on hill farms. The Veterinary record 2022. link

    Original source

    1. [1]
      Managing liver fluke on hill farms.Carson A, Jones B, Grove-White D The Veterinary record (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG